University of California San Francisco

Peter Stock, MD
Peter
Stock
MD, PhD

Professor of Surgery
Surgical Director, Kidney and Pancreas Transplant Program
Surgical Director, Pediatric Renal Transplant Program
Co-Director, Pancreatic Islet Cell Transplant Program
Program, Director, T32 Training Program in Transplant Surgery

Address

505 Parnassus Avenue, #M884A
San Francisco, CA 94117
United States

Email: [email protected]
Phone: 415-502-1735
Fax: 415-353-8974

Biography

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program.

In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy).

Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.

Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies.

Videos

Awards & Honors

Award Conferred By Date
James IVth Fellowship Award US Representative 2000
Faculty Fellowship Award American College of Surgeons 1993
Sandoz Fellowship Award American Society of Transplant Surgeons 1991
Outstanding Surgical Resident Teaching Award Department of Surgery, University of Minnesota, Minneapolis, MN 1989
David Gaviser Award, Outstanding Surgical Research University of Minnesota, Minneapolis, MN 1989
Outstanding Research Award, Senior Medical Student University of Illinois, Chicago, IL 1982
Alpha Omega Alpha University of Illinois, Chicago, IL 1981
Magna Cum Laude, Honors in Biology with High Distinction University of Illinois, Urbana, IL 1978
Phi Beta Kappa University of Illinois, Urbana, IL 1978

Education

Institution Degree Dept or School End Date
University of California, San Francisco Post-Doc Fellow/Scholar Medicine 1991
University of Illinois M.D. School of Medicine 1982
University of California, San Francisco Residency

Board Certifications

  • American Board of Surgery, 1991

Clinical Expertise

Bile Duct Injuries
Bile Duct Strictures
Cholangiocarcinoma (Bile Duct Cancer)
Choledochal Cyst Disease
Dialysis Access
End-Stage Kidney Disease
Fulminant Hepatic Failure
Hepatocellular Carcinoma (Liver Cancer)
Hepatitis B
Hepatitis C
Kidney Transplantation
Kidney and LIver Transplantation in HIV Patients
Liver Transplantation
Living Donor Liver Transplantation
Living Donor Kidney Transplantation
Pediatric Liver Transplantation
Pediatric Kidney Transplantation
Pancreatic Islet Cell Transplantation
Pancreas Transplantation
Polycystic Kidney Disease
Polycystic Liver Disease
Portal Hypertension

 

Clinical Trials

  1. Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes (NCT03977662)
    Related Conditions: Diabetes, Diabetes Type 1| Start Date: | End Date:
  2. HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients (NCT03500315)
    Related Conditions: HIV/AIDS, Kidney Transplant, Transplants| Start Date: | End Date:
  3. Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients (NCT02741323)
    Related Conditions: HIV/AIDS, Kidney Disease, Kidney Transplant, Transplants| Start Date: | End Date:
  4. Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant (NCT02533934)
    Related Conditions: HIV/AIDS, Hepatitis C, Cirrhosis, Fibrosis, Liver Transplant, Hepatitis A, Hepatitis| Start Date: | End Date:
  5. Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant (NCT02429869)
    Related Conditions: HIV/AIDS, Kidney Transplant, Transplants, Liver Transplant| Start Date: | End Date:
  6. Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus (NCT00501709)
    Related Conditions: Diabetes, Diabetes Type 1| Start Date: | End Date:
  7. Kidney and Liver Transplantation in People With HIV (NCT00074386)
    Related Conditions: HIV/AIDS, Kidney Disease, Liver Disease, Liver Transplant| Start Date: | End Date:

Program Affiliations

UCSF Liver Center

UCSF Diabetes Center

UCSF Helen Diller Family Comprehensive Cancer Center

Book Chapters

Zarinsefat A, Stock P. Islet vs. pancreas transplantation in nonuremic patients with type 1 diabetes. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas. 2020 Jan 1; 417-423.

Stock PG, Mukhtar R, Ghersin H, Fiscalini AS, and Esserman L. Pragmatic Trials and Approaches to Transforming Care. In: Pawlik T.,Sosa J. (eds). Clinical Trials. Success in Academic Surgery. Springer, Cham. 2020 March 11; 59-76. https://doi.org/10.1007/978-3-030-35488-6_6

Locke J, Stock P. Renal Transplantation 7th Ed. Editor(s): Mulholland MW, Lillemoe KD, Doherty GM, Maier RV, Simeone DM, Unchurch Jr GR. G. Greenfield’s Surgery: Scientific Principles and Practice: Lippincott Williams and Wilkens, Philadelphia. In press.

Grants and Funding

  • Filling a Void of Research (FAVOR) Training for Transplant Surgeons | NIH | 2016-08-01 - 2026-07-31 | Role: Principal Investigator
  • Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients | NIH | 2015-08-19 - 2022-07-31 | Role: Principal Investigator
  • Diabetes Research Center | NIH | 2002-09-01 - 2021-03-31 | Role: Co-Investigator
  • Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant | NIH | 2015-01-15 - 2019-12-31 | Role: Principal Investigator
  • Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients | NIH | 2013-05-15 - 2015-04-30 | Role: Principal Investigator
  • Solid Organ Transplantation in HIV: Multi-Site Study | NIH | 2003-08-15 - 2013-08-31 | Role: Principal Investigator
  • General Clinical Research Center | NIH | 1974-12-01 - 2009-03-31 | Role: Co-Investigator

Research Narrative

During the last 3 years, the major thrust of my research and creative activities have focused in three areas, which are listed below along with related NIH and extramural funding covering the research since the last advancement (2018):

  1. Improving the outcomes of solid organ transplantation in people with HIV and translational studies bridging the previously distinct worlds of HIV and transplantation. Related funding during last 3 years: A) NIH U01Al118594-05 – Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients (Stock PI)(active until 07/31/2021); B) NIH U01 Hope in Action Prospective Multi-Center Trial (Stock Site PI)(active until 07/31/3021); C) NIHU01 Al152153-01 – Maximizing the success of HIV+ to HIV+ Kidney Transplantation in South Africa (Stock Co-Investigator)(active until 03/31/2025); D) NIH U01 A1115714-03 Sofusbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant (Stock PI)(funding ended 12/31/19); E) American Foundation for AIDS Research (amfAR) 109119-57-RGRL – Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant (Stock PI)(funding ended 01/31/2018).
  2. Beta Cell Replacement strategies for the treatment of diabetes mellitus with pancreas transplantation, islet transplantation, or stem cell-derived beta cell clusters. We were funded ($11-million dollar grant) from CIRM to develop the forearm as a site for islet cell transplantation. This novel approach uses co-transplantation of islets with parathyroid tissue to facilitate engraftment – and has the potential for the development of a safe and accessible site for stem cell-derived beta cells. Related funding during last 3 years: A) California Institute for Regenerative Medicine (CIRM) – Islet and PARAthyroid Co-Transplantation for Treatment of Diabetes in Intra-Muscular Site (PARADIGM) (Stock PI) (active until 06/30/2023); B) NIH/NIDDK P30 DK063720 Diabetes Endocrinology Research Center (Stock Director of the Islet Production Core, German PI) (funding end 03/31/2020, renewal pending).
  3. Public Policy/Organ Allocation: During the last 3 years, I continue to have an active role in the development of national allocation policy. Based on previous experience as the Chair of both the national pancreas and kidney committees of UNOS, I have been funded as a senior investigator of the Scientific Registry of Transplant Recipients (SRTR). The SRTR is contracted by the government (HRSA) to provide analysis based on the national data registry to guide policy development. Related funding during last 3 years: HSRA 75R60220C00011 (annual funding – contract to continue thru 2025).

In addition to the public policy development guided by the SRTR, I have served as the Chair of the Ethics Committee of The Transplantation Society, which guides international policies regarding the complex ethical issues involved in transplantation (see Professional Competence below).

 

Pancreatic Islet Transplantation
The translational research in the field of pancreatic islets revolves around clinical trials of the safety and efficacy of islet transplantation in patients with Type I diabetes. The clinical trials are funded by the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation (JDRF). These clinical trials focus on novel immunosuppressive strategies that utilize co-stimulatory blockade to prevent the immune response against pancreatic islets with a regimen that is not toxic to kidneys or beta cells.

Related research involves improving the techniques required for isolating pancreatic islets from the pancreas, which is being conducted in a fully compliant GMP laboratory facility. The study of the alloimmune and autoimmune response following islet transplantation will be conducted to determine the efficacy of the immunosuppressive strategies. Further translational studies will include methods of expanding the source of beta cells, using direct proliferation, as well as manipulation of precursor cells localized in the adult pancreas. We are currently funded (PI) for a translational grant from California Institute of Regenerative Medicine (CIRM) to bring embryonic stem cell-derived beta cells to a clinical trial.

Solid Organ Transplantation in People with HIV
With the advent of highly active anti-retroviral therapy (HAART), HIV has been a chronic disease. People with HIV are no longer dying from progression of HIV to AIDS, but rather as a result of end stage live disease (viral hepatitis co-infection) and kidney disease (HIV nephropathy). Our laboratory heads up the large NIH-sponsored national multicenter trial which is studying the safety and efficacy of solid organ transplantation in people with HIV. Translational research is exploring the impact of HIV on organ function and the impact of immunosuppression on the immune response against HIV and associated copathogens.

Research Interests

Induction of transplantation tolerance to block alloimmunity and recurrent autoimmunity following pancreatic islet transplantation

Safety and efficacy of solid organ transplantation in people with HIV

Research Pathways

Basic Biomedical & Translational Research
Clinical Discovery & Health Services Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 287
  1. Transplantation: A Priority in the Healthcare Agenda.
    Muller E, Dominguez-Gil B, Ahn C, Berenguer M, Cardillo M, Chatzixiros E, Cortesi P, Herson M, Ilbawi A, Jha V, Mahillo B, Manas DM, Nino-Murcia A, Shaheen FAM, Stock P, Potena L| | PubMed
  2. Safety of Kidney Transplantation from Donors with HIV.
    Durand CM, Massie A, Florman S, Liang T, Rana MM, Friedman-Moraco R, Gilbert A, Stock P, Mehta SA, Mehta S, Stosor V, Pereira MR, Morris MI, Hand J, Aslam S, Malinis M, Haidar G, Small CB, Santos CAQ, Schaenman J, Baddley J, Wojciechowski D, Blumberg EA, Ranganna K, Adebiyi O, Elias N, Castillo-Lugo JA, Giorgakis E, Apewokin S, Brown D, Ostrander D, Eby Y, Desai N, Naqvi F, Bagnasco S, Watson N, Brittain E, Odim J, Redd AD, Tobian AAR, Segev DL, HOPE in Action Investigators| | PubMed
  3. Gene Expression-based Molecular Scoring of Pancreas Transplant Rejection for a Quantitative Assessment of Rejection Severity and Resistance to Treatment.
    Brown AE, Kelly YM, Zarinsefat A, Meier RPH, Worner G, Tavakol M, Sarwal MM, Laszik ZG, Stock PG, Sigdel TK| | PubMed
  4. Long-term impact of immigration status on outcomes in pediatric kidney transplant recipients.
    Nunez M, Abbasi A, McEnhill M, Brennan J, Shappell T, Kinnier S, Winnicki E, Stock P| | PubMed
  5. An Enhanced Role of Innate Immunity in the Immune Response After Kidney Transplant in People Living With HIV: A Transcriptomic Analysis.
    Zarinsefat A, Dobi D, Kelly YM, Szabo G, Henrich T, Laszik ZG, Stock PG| | PubMed
  6. Consent for High-Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right.
    Stock P, Rickert CG| | PubMed
  7. Transplantation in the Context of Migration and Refugees: A Summary of the DICG and TTS Ethics Committee Workshop, Buenos Aires, Argentina, September 2022.
    Stock PG, Nagral S, Rondeau E, Gawronska S, Groverman J, Barbari A, Coates PT, Domínguez-Gil B, Fadhil R, Malyszko J, Niño Murcia A| | PubMed
  8. OPTN/SRTR 2022 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Miller JM, Booker SE, White J, Israni AK, Snyder JJ| | PubMed
  9. Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act.
    Motter JD, Hussain S, Brown DM, Florman S, Rana MM, Friedman-Moraco R, Gilbert AJ, Stock P, Mehta S, Mehta SA, Stosor V, Elias N, Pereira MR, Haidar G, Malinis M, Morris MI, Hand J, Aslam S, Schaenman JM, Baddley J, Small CB, Wojciechowski D, Santos CAQ, Blumberg EA, Odim J, Apewokin SK, Giorgakis E, Bowring MG, Werbel WA, Desai NM, Tobian AAR, Segev DL, Massie AB, Durand CM, HOPE in Action Investigators| | PubMed
  10. Next Steps for Clinical Xenotransplantation in the United States.
    Schiff T, Parent B, Dittmer I, Hawthorne WJ, Kwon I, Mohiuddin MM, Park CG, Stock P, Pierson RN| | PubMed
  11. Expanding Access to Organ Transplant for People Living With HIV: Can Policy Catch Up to Outcomes Data?
    Chandran S, Stock PG, Roll GR| | PubMed
  12. A Multi-Modal Approach to Islet and Pancreas Transplantation With Calcineurin-Sparing Immunosuppression Maintains Long-Term Insulin Independence in Patients With Type I Diabetes.
    Wisel SA, Posselt AM, Szot GL, Nunez M, Santos-Parker K, Gardner JM, Worner G, Roll GR, Syed S, Kelly Y, Ward C, Tavakol M, Johnson K, Masharani U, Stock PG| | PubMed
  13. The John S. Najarian symposium: The past, present, and future of surgery and transplantation, May 20, 2022, Minneapolis, MN.
    Knatterud ME, Simmons RL, Payne W, Stock P, Chavers B, Ascher N, Kaufman D, Kirk A, Keshavjee S, Humar A, Ganesh S, Hughes C, Kandaswamy R, Matas AJ| | PubMed
  14. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
    Roll GR, Bray RA, Cooper M, Eagar TN, Gebel HM, Vranic GM, Hitchman KMK, Houp J, Kamoun M, Killian J, Kim J, Kumar V, Levine M, Lovasik BP, Lunow-Luke T, Parsons RF, Pattanayak V, Ranch D, Shah A, Stock PG, Timofeeva OA, Trofe-Clark J, Wongjirad C, Yeh H, Yi S, Rajalingam R| | PubMed
  15. OPTN/SRTR 2021 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Miller JM, White J, Booker SE, Israni AK, Snyder JJ| | PubMed
  16. The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir.
    Benner SE, Eby Y, Zhu X, Fernandez RE, Patel EU, Ruff JE, Habtehyimer F, Schmidt HA, Kirby CS, Hussain S, Ostrander D, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock P, Gilbert A, Morris MI, Stosor V, Mehta SA, Small CB, Ranganna K, Santos CA, Aslam S, Husson J, Malinis M, Elias N, Blumberg EA, Doby BL, Massie AB, Smith ML, Odim J, Quinn TC, Laird GM, Siliciano RF, Segev DL, Redd AD, Durand CM, Tobian AA| | PubMed
  17. Erratum.
    Kandaswamy R, Stock PG, Miller J, White J, Booker SE, Israni AK, Snyder JJ| | PubMed
  18. Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
    Kwong AJ, Kim WR, Lake J, Stock PG, Wang CJ, Wetmore JB, Melcher ML, Wey A, Salkowski N, Snyder JJ, Israni AK| | PubMed
  19. Maximizing HIV Organ Policy Equity for transplant candidates with HIV.
    Boyarsky BJ, Durand CM, Stock PG| | PubMed
  20. A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation.
    Berney T, Andres A, Bellin MD, de Koning EJP, Johnson PRV, Kay TWH, Lundgren T, Rickels MR, Scholz H, Stock PG, White S, International Islet Transplant Centers| | PubMed
  21. Considerations For Use of Propensity Score Matching in Specific Patient Populations-Reply.
    Zarinsefat A, Shui A, Stock P| | PubMed
  22. International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation.
    Ward C, Odorico JS, Rickels MR, Berney T, Burke GW, Kay TWH, Thaunat O, Uva PD, de Koning EJP, Arbogast H, Scholz H, Cattral MS, Stratta RJ, Stock PG,
    for the International Pancreas and Islet Transplant Association Bet    | | PubMed
  23. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
    Werbel WA, Brown DM, Kusemiju OT, Doby BL, Seaman SM, Redd AD, Eby Y, Fernandez RE, Desai NM, Miller J, Bismut GA, Kirby CS, Schmidt HA, Clarke WA, Seisa M, Petropoulos CJ, Quinn TC, Florman SS, Huprikar S, Rana MM, Friedman-Moraco RJ, Mehta AK, Stock PG, Price JC, Stosor V, Mehta SG, Gilbert AJ, Elias N, Morris MI, Mehta SA, Small CB, Haidar G, Malinis M, Husson JS, Pereira MR, Gupta G, Hand J, Kirchner VA, Agarwal A, Aslam S, Blumberg EA, Wolfe CR, Myer K, Wood RP, Neidlinger N, Strell S, Shuck M, Wilkins H, Wadsworth M, Motter JD, Odim J, Segev DL, Durand CM, Tobian AAR, HOPE in Action Investigators| | PubMed
  24. Pancreas Transplantation for Type 2 Diabetes: A Systematic Review, Critical Gaps in the Literature, and a Path Forward.
    Amara D, Hansen KS, Kupiec-Weglinski SA, Braun HJ, Hirose R, Hilton JF, Rickels MR, Odorico JS, Stock PG| | PubMed
  25. Effects of Multi-stage Procurement on the Viability and Function of Human Donor Parathyroid Glands.
    Kelly YM, Ward C, Zhang R, Syed S, Stock PG, Duh QY, Sosa JA, Koh J| | PubMed
  26. HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologist.
    Russo FP, Viganò M, Stock P, Ferrarese A, Pugliese N, Burra P, Aghemo A| | PubMed
  27. Procurement of Deceased Donor Parathyroid Glands With the Aid of Near-infrared Autofluorescence Imaging.
    Ward CJ, Kelly YM, Syed SM, Meier RPH, Ando T, Wisel SA, Gardner JM, Stock PG, Duh QY| | PubMed
  28. Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV.
    Zarinsefat A, Gulati A, Shui A, Braun H, Rogers R, Hirose R, Ascher N, Stock P| | PubMed
  29. OPTN/SRTR 2020 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Miller J, White J, Booker SE, Israni AK, Snyder JJ| | PubMed
  30. International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System.
    Braun HJ, Amara D, Shui AM, Stock PG, Hirose R, Delmonico FL, Ascher NL| | PubMed
  31. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
    Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| | PubMed
  32. COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.
    Chandran S, Stock PG| | PubMed
  33. HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV.
    Durand CM, Florman S, Motter JD, Brown D, Ostrander D, Yu S, Liang T, Werbel WA, Cameron A, Ottmann S, Hamilton JP, Redd AD, Bowring MG, Eby Y, Fernandez RE, Doby B, Labo N, Whitby D, Miley W, Friedman-Moraco R, Turgeon N, Price JC, Chin-Hong P, Stock P, Stosor V, Kirchner VA, Pruett T, Wojciechowski D, Elias N, Wolfe C, Quinn TC, Odim J, Morsheimer M, Mehta SA, Rana MM, Huprikar S, Massie A, Tobian AAR, Segev DL, HOPE in Action Investigators| | PubMed
  34. Ethical review of COVID-19 vaccination requirements for transplant center staff and patients.
    Kates OS, Stock PG, Ison MG, Allen RDM, Burra P, Jeong JC, Kute V, Muller E, Nino-Murcia A, Wang H, Wall A| | PubMed
  35. Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.
    Landstra CP, Andres A, Chetboun M, Conte C, Kelly Y, Berney T, de Koning EJP, Piemonti L, Stock PG, Pattou F, Vantyghem MC, Bellin MD, Rickels MR| | PubMed
  36. Maximizing the use of hard to place kidneys: Getting the right kidney to the right recipient at the right time.
    Stock PG, Lentine KL| | PubMed
  37. First World Consensus Conference on pancreas transplantation: Part II - recommendations.
    Boggi U, Vistoli F, Andres A, Arbogast HP, Badet L, Baronti W, Bartlett ST, Benedetti E, Branchereau J, Burke GW, Buron F, Caldara R, Cardillo M, Casanova D, Cipriani F, Cooper M, Cupisti A, Davide J, Drachenberg C, de Koning EJP, Ettorre GM, Fernandez Cruz L, Fridell JA, Friend PJ, Furian L, Gaber OA, Gruessner AC, Gruessner RWG, Gunton JE, Han DJ, Iacopi S, Kauffmann EF, Kaufman D, Kenmochi T, Khambalia HA, Lai Q, Langer RM, Maffi P, Marselli L, Menichetti F, Miccoli M, Mittal S, Morelon E, Napoli N, Neri F, Oberholzer J, Odorico JS, Öllinger R, Oniscu G, Orlando G, Ortenzi M, Perosa M, Perrone VG, Pleass H, Redfield RR, Ricci C, Rigotti P, Paul Robertson R, Ross LF, Rossi M, Saudek F, Scalea JR, Schenker P, Secchi A, Socci C, Sousa Silva D, Squifflet JP, Stock PG, Stratta RJ, Terrenzio C, Uva P, Watson CJE, White SA, Marchetti P, Kandaswamy R, Berney T| | PubMed
  38. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
    Stock PG, Henrich TJ, Segev DL, Werbel WA| | PubMed
  39. Kidney Transplantation in HIV-positive Patients: Current Practice and Management Strategies.
    Muller E, Botha FCJ, Barday ZA, Manning K, Chin-Hong P, Stock P| | PubMed
  40. Tests for the noninvasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs.
    Danovitch GM, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall MD, Steiner RW, Stock PG, Vincenti F| | PubMed
  41. New Kidney and Pancreas Allocation Policy: Moving to a Circle as the First Unit of Allocation.
    Israni A, Wey A, Thompson B, Miller J, Casingal V, Pavlakis M, Niederhaus S, Forbes R, Wilk A, McKinney W, Kandaswamy R, Stock P, Snyder J| | PubMed
  42. COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.
    Roll GR, Lunow-Luke T, Braun HJ, Buenaventura O, Mallari M, Stock PG, Rajalingam R| | PubMed
  43. Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
    Braun HJ, Dodge JL, Grab JD, Schwab ME, Liu IH, Glencer AC, Stock PG, Hirose R, Roberts JP, Ascher NL| | PubMed
  44. Utility of a Simplified Iliac Artery Calcium Scoring System to Guide Perioperative Management for Renal Transplantation.
    Werlin EC, Braun HJ, Walker JP, Freise JE, Amara D, Liu IH, Mello A, Tavakol M, Stock PG, Hiramoto JS| | PubMed
  45. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.
    Witkowski P, Philipson LH, Kaufman DB, Ratner LE, Abouljoud MS, Bellin MD, Buse JB, Kandeel F, Stock PG, Mulligan DC, Markmann JF, Kozlowski T, Andreoni KA, Alejandro R, Baidal DA, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker YT, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia JL, Stratta RJ, Fridell JA, Niederhaus SV, Forbes RC, Jayant K, Robertson RP, Odorico JS, Levy MF, Harland RC, Abrams PL, Olaitan OK, Kandaswamy R, Wellen JR, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C, “Islets for US” Collaborative| | PubMed
  46. OPTN/SRTR 2019 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Miller J, Skeans MA, White J, Wainright J, Kyaw NTT, Niederhaus S, Israni AK, Snyder JJ| | PubMed
  47. Long-term Lower Extremity and Cardiovascular Complications after Simultaneous Pancreas-Kidney Transplant.
    Amara D, Braun HJ, Shui AM, Sorrentino T, Ramirez JL, Lin J, Liu IH, Mello A, Stock PG, Hiramoto JS| | PubMed
  48. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
    Peters MG, Kottilil S, Terrault N, Amara D, Husson J, Huprikar S, Florman S, Sulkowski MS, Durand CM, Luetkemeyer AF, Rogers R, Grab J, Haydel B, Blumberg E, Dove L, Emond J, Olthoff K, Smith C, Fishbein T, Masur H, Stock PG| | PubMed
  49. Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies.
    Amara D, Wisel SA, Braun HJ, Collisson EA, Friedlander T, Worner G, Roll GR, Hirose R, Stock PG| | PubMed
  50. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
    Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C| | PubMed
  51. How COVID-19 inspired surgical residents to rethink educational programs.
    Brian R, Stock P, Syed S, Hirose K, Reilly L, O'Sullivan P| | PubMed
  52. Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study.
    Meier RPH, Noguchi H, Kelly YM, Sarwal M, Conti G, Ward C, Halleluyan R, Tavakol M, Stock PG, Freise CE| | PubMed
  53. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.
    Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG| | PubMed
  54. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.
    Markmann JF, Rickels MR, Eggerman TL, Bridges ND, Lafontant DE, Qidwai J, Foster E, Clarke WR, Kamoun M, Alejandro R, Bellin MD, Chaloner K, Czarniecki CW, Goldstein JS, Hering BJ, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Naji A, Oberholzer J, Posselt AM, Ricordi C, Senior PA, Shapiro AMJ, Stock PG, Turgeon NA| | PubMed
  55. A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action.
    Durand CM, Zhang W, Brown DM, Yu S, Desai N, Redd AD, Bagnasco SM, Naqvi FF, Seaman S, Doby BL, Ostrander D, Bowring MG, Eby Y, Fernandez RE, Friedman-Moraco R, Turgeon N, Stock P, Chin-Hong P, Mehta S, Stosor V, Small CB, Gupta G, Mehta SA, Wolfe CR, Husson J, Gilbert A, Cooper M, Adebiyi O, Agarwal A, Muller E, Quinn TC, Odim J, Huprikar S, Florman S, Massie AB, Tobian AAR, Segev DL, HOPE in Action Investigators| | PubMed
  56. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial.
    Mannon RB, Armstrong B, Stock PG, Mehta AK, Farris AB, Watson N, Morrison Y, Sarwal M, Sigdel T, Bridges N, Robien M, Newell KA, Larsen CP| | PubMed
  57. Ethical Issues in the COVID Era: Doing the Right Thing Depends on Location, Resources, and Disease Burden.
    Stock PG, Wall A, Gardner J, Domínguez-Gil B, Chadban S, Muller E, Dittmer I, Tullius SG, TTS Ethics Committee| | PubMed
  58. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
    Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R| | PubMed
  59. Inferior Long-Term Graft Survival of Suboptimal Kidneys After Living Donor Kidney Transplantation.
    Yamanaga S, Freise CE, Stock PG, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Kang SM| | PubMed
  60. Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce health-care resources in transplant allocation decisions.
    Wall AE, Pruett T, Stock P, Testa G| | PubMed
  61. Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial.
    Stock PG, Mannon RB, Armstrong B, Watson N, Ikle D, Robien MA, Morrison Y, Odorico J, Fridell J, Mehta AK, Newell KA| | PubMed
  62. Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.
    Roll GR, Posselt AM, Freise J, Baird J, Syed S, Mo Kang S, Hirose R, Szot GL, Zarinsefat A, Feng S, Worner G, Sarwal M, Stock PG| | PubMed
  63. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation.
    Fozouni L, Mohamad Y, Lebsack A, Freise C, Stock P, Lai JC| | PubMed
  64. OPTN/SRTR 2018 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Urban R, Fox A, Israni AK, Snyder JJ, Kasiske BL| | PubMed
  65. Organs From Executed People Are Not a Source of Scientific Discovery.
    Chapman JR, Stock P, Haberal M| | PubMed
  66. OPTN/SRTR 2017 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Urban R, Fox A, Odorico JS, Israni AK, Snyder JJ, Kasiske BL| | PubMed
  67. Oxygen Perfusion (Persufflation) of Human Pancreata Enhances Insulin Secretion and Attenuates Islet Proinflammatory Signaling.
    Kelly AC, Smith KE, Purvis WG, Min CG, Weber CS, Cooksey AM, Hasilo C, Paraskevas S, Suszynski TM, Weegman BP, Anderson MJ, Camacho LE, Harland RC, Loudovaris T, Jandova J, Molano DS, Price ND, Georgiev IG, Scott WE, Manas DMD, Shaw JAM, O'Gorman D, Kin T, McCarthy FM, Szot GL, Posselt AM, Stock PG, Karatzas T, Shapiro AMJ, Lynch RM, Limesand SW, Papas KK| | PubMed
  68. Global Surgery: Effective Involvement of US Academic Surgery: Report of the American Surgical Association Working Group on Global Surgery.
    Mock C, Debas H, Balch CM, Brennan M, Buyske J, Cusack J, DeMeester S, Herndon D, Le Holterman AX, Jaffe B, Kandil E, Kauffman G, Mazariegos G, sMerchant N, Numann P, Oleynikov D, Olutoye O, O'Neill J, Shackford S, Stock P, Tarpley JL, Tuttle T, Wolf S, Wren SM, Yang GP| | PubMed
  69. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.
    Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S| | PubMed
  70. Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.
    Durand CM, Halpern SE, Bowring MG, Bismut GA, Kusemiju OT, Doby B, Fernandez RE, Kirby CS, Ostrander D, Stock PG, Mehta S, Turgeon NA, Wojciechowski D, Huprikar S, Florman S, Ottmann S, Desai NM, Cameron A, Massie AB, Tobian AAR, Redd AD, Segev DL| | PubMed
  71. Inferior long-term graft survival after end-to-side reconstruction for two renal arteries in living donor renal transplantation.
    Yamanaga S, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Stock PG, Kang SM| | PubMed
  72. Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.
    Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, Hebrok M| | PubMed
  73. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.
    Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S| | PubMed
  74. Defining outcomes for beta cell replacement therapy: a work in progress.
    Piemonti L, de Koning EJP, Berney T, Odorico JS, Markmann JF, Stock PG, Rickels MR| | PubMed
  75. β Cell Replacement Therapy: The Next 10 Years.
    Schuetz C, Anazawa T, Cross SE, Labriola L, Meier RPH, Redfield RR, Scholz H, Stock PG, Zammit NW, IPITA YIC Young Investigator Committee| | PubMed
  76. OPTN/SRTR 2016 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Curry MA, Prentice MA, Fox A, Israni AK, Snyder JJ, Kasiske BL| | PubMed
  77. Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipient.
    Stock PG| | PubMed
  78. Splenic Vein Thrombosis Following Pancreas Transplantation: Identification of Factors That Support Conservative Management.
    Harbell JW, Morgan T, Feldstein VA, Roll GR, Posselt A, Kang SM, Feng S, Hirose R, Freise CE, Stock P| | PubMed
  79. Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.
    Newell KA, Mehta AK, Larsen CP, Stock PG, Farris AB, Mehta SG, Ikle D, Armstrong B, Morrison Y, Bridges N, Robien M, Mannon RB| | PubMed
  80. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.
    O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE| | PubMed
  81. Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428.
    Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant DE, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Friberg AS, Lei J, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AMJ| | PubMed
  82. Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.
    Wisel SA, Gardner JM, Roll GR, Harbell J, Freise CE, Feng S, Kang SM, Hirose R, Kaufman DB, Posselt AM, Stock PG| | PubMed
  83. Hemophilia Liver Transplantation Observational Study.
    Ragni MV, Humar A, Stock PG, Blumberg EA, Eghtesad B, Fung JJ, Stosor V, Nissen N, Wong MT, Sherman KE, Stablein DM, Barin B| | PubMed
  84. Reply to Comment on the Article "OPTN/SRTR 2015 Annual Data Report: Pancreas".
    Kandaswamy R, Stock PG, Gustafson SK, Skeans M, Thompson B, Kasiske BL| | PubMed
  85. Canadian Laws Are on Target-But Is the Transplant Community?
    Rogers RL, Stock PG| | PubMed
  86. Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals.
    Chandran S, Stock PG| | PubMed
  87. OPTN/SRTR 2015 Annual Data Report: Early effects of the new kidney allocation system.
    Hart A, Gustafson SK, Skeans MA, Stock P, Stewart D, Kasiske BL, Israni AK| | PubMed
  88. OPTN/SRTR 2015 Annual Data Report: Pancreas.
    Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Curry MA, Prentice MA, Israni AK, Snyder JJ, Kasiske BL| | PubMed
  89. Strategies to improve outcomes for hepatitis C virus/human immunodeficiency virus coinfected liver transplant candidates.
    Roll GR, Stock PG| | PubMed
  90. Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation system.
    Stegall MD, Stock PG, Andreoni K, Friedewald JJ, Leichtman AB| | PubMed
  91. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus.
    Campos-Varela I, Dodge JL, Stock PG, Terrault NA| | PubMed
  92. Current outcomes in islet versus solid organ pancreas transplant for β-cell replacement in type 1 diabetes.
    Wisel SA, Braun HJ, Stock PG| | PubMed
  93. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities.
    Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant DE, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Chen X, Friberg AS, Lei J, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AM, Chen X| | PubMed
  94. Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell Replacement.
    Markmann JF, Bartlett ST, Johnson P, Korsgren O, Hering BJ, Scharp D, Kay TW, Bromberg J, Odorico JS, Weir GC, Bridges N, Kandaswamy R, Stock P, Friend P, Gotoh M, Cooper DK, Park CG, O'Connell PJ, Stabler C, Matsumoto S, Ludwig B, Choudhary P, Khovatchev B, Rickels MR, Sykes M, Wood K, Kraemer K, Hwa A, Stanley E, Ricordi C, Zimmerman M, Greenstein J, Montanya E, Otonkoski T| | PubMed
  95. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.
    Hering BJ, Clarke WR, Bridges ND, Eggerman TL, Alejandro R, Bellin MD, Chaloner K, Czarniecki CW, Goldstein JS, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Markmann JF, Naji A, Oberholzer J, Posselt AM, Rickels MR, Ricordi C, Robien MA, Senior PA, Shapiro AM, Stock PG, Turgeon NA, Clinical Islet Transplantation Consortium| | PubMed
  96. A Path to Insulin Independence: "The End of the Beginning".
    Stock PG, German MS| | PubMed
  97. Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis.
    Fix OK, Stock PG, Lee BK, Benson MD| | PubMed
  98. Effect of Immigration Status on Outcomes in Pediatric Kidney Transplant Recipients.
    McEnhill ME, Brennan JL, Winnicki E, Lee MM, Tavakol M, Posselt AM, Stock PG, Portale AA| | PubMed
  99. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
    Bartlett ST, Markmann JF, Johnson P, Korsgren O, Hering BJ, Scharp D, Kay TW, Bromberg J, Odorico JS, Weir GC, Bridges N, Kandaswamy R, Stock P, Friend P, Gotoh M, Cooper DK, Park CG, O'Connell P, Stabler C, Matsumoto S, Ludwig B, Choudhary P, Kovatchev B, Rickels MR, Sykes M, Wood K, Kraemer K, Hwa A, Stanley E, Ricordi C, Zimmerman M, Greenstein J, Montanya E, Otonkoski T| | PubMed
  100. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.
    Roland ME, Barin B, Huprikar S, Murphy B, Hanto DW, Blumberg E, Olthoff K, Simon D, Hardy WD, Beatty G, Stock PG, HIVTR Study Team| | PubMed
  101. US Findings in Patients at Risk for Pancreas Transplant Failure.
    Morgan TA, Smith-Bindman R, Harbell J, Kornak J, Stock PG, Feldstein VA| | PubMed
  102. A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.
    Moassesfar S, Masharani U, Frassetto LA, Szot GL, Tavakol M, Stock PG, Posselt AM| | PubMed
  103. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.
    Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM, FIPSE/NIH HIVTR/NEAT023 Investigators| | PubMed
  104. A Source of Treatment for Those Who Were (Almost) Lost: Human Immunodeficiency Virus-Positive to Human Immunodeficiency Virus-Positive Kidney Transplantation-Results at 3 to 5 Years.
    Stock PG| | PubMed
  105. Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.
    Balagopal A, Barin B, Quinn J, Rogers R, Sulkowski MS, Stock PG| | PubMed
  106. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement.
    Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O'Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP, Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurem| | PubMed
  107. Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle.
    Stock PG, Terrault NA| | PubMed
  108. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.
    Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, Olthoff KM, Harper A, Snyder JJ, Israni AK, Kasiske BL, Kim WR| | PubMed
  109. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.
    Miro JM, Stock P, Teicher E, Duclos-Vallée JC, Terrault N, Rimola A| | PubMed
  110. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.
    Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC, HIV Medicine Association of the Infectious Diseases Society of America| | PubMed
  111. Management of hepatitis C in kidney transplant patients: on the cusp of change.
    Terrault NA, Stock PG| | PubMed
  112. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
    Lee RH, Roll G, Nguyen V, Willenbring H, Tang Q, Kang SM, Stock PG| | PubMed
  113. Human islet viability and function is maintained during high-density shipment in silicone rubber membrane vessels.
    Kitzmann JP, Pepper AR, Gala-Lopez B, Pawlick R, Kin T, O'Gorman D, Mueller KR, Gruessner AC, Avgoustiniatos ES, Karatzas T, Szot GL, Posselt AM, Stock PG, Wilson JR, Shapiro AM, Papas KK| | PubMed
  114. Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.
    Allen AM, Kim WR, Xiong H, Liu J, Stock PG, Lake JR, Chinnakotla S, Snyder JJ, Israni AK, Kasiske BL| | PubMed
  115. Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients.
    Stock PG, Barin B, Hatano H, Rogers RL, Roland ME, Lee TH, Busch M, Deeks SG, for Solid Organ Transplantation in HIV Study Investigators| | PubMed
  116. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients.
    Frassetto LA, Tan-Tam CC, Barin B, Browne M, Wolfe AR, Stock PG, Roland M, Benet LZ| | PubMed
  117. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
    Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P, HIVTR Investigators| | PubMed
  118. Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.
    Branch AD, Barin B, Rahman A, Stock P, Schiano TD| | PubMed
  119. Kidney infection with HIV-1 following kidney transplantation.
    Stock PG| | PubMed
  120. Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients.
    Frassetto L, Floren L, Barin B, Browne M, Wolfe A, Roland M, Stock P, Carlson L, Christians U, Benet L| | PubMed
  121. Solid organ transplants in HIV-infected patients.
    Harbell J, Terrault NA, Stock P| | PubMed
  122. Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease.
    Benedict KA, Moassesfar S, Adi S, Gitelman SE, Brennan JL, McEnhill M, Stock PG, Portale AA, Posselt AM| | PubMed
  123. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health mu
    Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K, Solid Organ Transplantation in HIV: Multi-Site Study Investigators| | PubMed
  124. Isolation and hepatocyte differentiation of mesenchymal stem cells from porcine bone marrow--"surgical waste" as a novel MSC source.
    Brückner S, Tautenhahn HM, Winkler S, Stock P, Jonas S, Dollinger M, Christ B| | PubMed
  125. Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.
    Chin-Hong P, Beatty G, Stock P| | PubMed
  126. Optimizing the program-specific reporting of pancreas transplant outcomes.
    Kasiske BL, Gustafson S, Salkowski N, Stock PG, Axelrod DA, Kandaswamy R, Sleeman EF, Wainright J, Israni AK, Snyder JJ| | PubMed
  127. Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility.
    Ansari IU, Allen T, Berical A, Stock PG, Barin B, Striker R| | PubMed
  128. OPTN/SRTR 2011 Annual Data Report: liver.
    Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, Harper AM, Snyder JJ, Israni AK, Kasiske BL| | PubMed
  129. OPTN/SRTR 2011 Annual Data Report: pancreas.
    Kandaswamy R, Stock PG, Skeans MA, Gustafson SK, Sleeman EF, Wainright JL, Carrico RJ, Ghimire V, Snyder JJ, Israni AK, Kasiske BL| | PubMed
  130. Kidney, pancreas and liver allocation and distribution in the United States.
    Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF, Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK| | PubMed
  131. Malignancy in the HIV-infected patients undergoing liver and kidney transplantation.
    Nissen NN, Barin B, Stock PG| | PubMed
  132. Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.
    Harbell J, Fung J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Roland ME, Stock PG, HIV-TR Investigators| | PubMed
  133. Liver transplant outcomes in HIV+ haemophilic men.
    Ragni MV, Devera ME, Roland ME, Wong M, Stosor V, Sherman KE, Hardy D, Blumberg E, Fung J, Barin B, Stablein D, Stock PG| | PubMed
  134. Liver transplantation in HIV patients.
    Fox AN, Vagefi PA, Stock PG| | PubMed
  135. Improvement in outcomes of clinical islet transplantation: 1999-2010.
    Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon NA, Witkowski P, Naji A, O'Connell PJ, Greenbaum C, Kudva YC, Brayman KL, Aull MJ, Larsen C, Kay TW, Fernandez LA, Vantyghem MC, Bellin M, Shapiro AM| | PubMed
  136. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG, Solid Organ Transplantation in HIV: Multi-Site Study Investigators| | PubMed
  137. Development of organ-specific donor risk indices.
    Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK| | PubMed
  138. The Effect of HLA-DR Matching on Pediatric Kidney Transplantation-Reply.
    Stock PG| | PubMed
  139. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT, Baxter-Lowe LA, Garcia J, McEnhill M, Summers P, Hirose R, Lee M, Stock PG| | PubMed
  140. The risk and opportunity of homeostatic repopulation.
    Stock P, Kirk AD| | PubMed
  141. Transplant surgery fellow perceptions about training and the ensuing job market-are the right number of surgeons being trained?
    Reich DJ, Magee JC, Gifford K, Merion RM, Roberts JP, Klintmalm GB, Stock PG, ASTS Fellowship Training Committee| | PubMed
  142. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.
    Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG| | PubMed
  143. Outcomes of kidney transplantation in HIV-infected recipients.
    Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME| | PubMed
  144. An analysis of the lack of donor pancreas utilization from younger adult organ donors.
    Wiseman AC, Wainright JL, Sleeman E, McBride MA, Baker T, Samana C, Stock P| | PubMed
  145. Role of PD-L1 and PD-L2 in allergic diseases and asthma.
    Singh AK, Stock P, Akbari O| | PubMed
  146. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
    Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG| | PubMed
  147. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
    Coffin CS, Stock PG, Dove LM, Berg CL, Nissen NN, Curry MP, Ragni M, Regenstein FG, Sherman KE, Roland ME, Terrault NA| | PubMed
  148. Clinical islet transplantation at the University of California, San Francisco.
    Posselt AM, Szot GL, Frassetto LA, Masharani U, Stock PG| | PubMed
  149. Kidney transplantation at UCSF: 8,300 transplants and onward.
    Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O| | PubMed
  150. Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence.
    Mukhtar RA, Baskin LS, Stock PG, Lee H| | PubMed
  151. Solid organ transplantation in the HIV-infected patient.
    Blumberg EA, Stock P, AST Infectious Diseases Community of Practice| | PubMed
  152. Liver and kidney transplantation in HIV-infected patients.
    Tan-Tam CC, Frassetto LA, Stock PG| | PubMed
  153. Renal transplantation in patients with HIV.
    Frassetto LA, Tan-Tam C, Stock PG| | PubMed
  154. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.
    Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Florman S, Blumberg E, Stosor V, Jayaweera DT, Huprikar S, Fung J, Pruett T, Stock P, Ragni M| | PubMed
  155. Promotion of altruistic donation.
    Tilney N, Murray J, Thistlethwaite R, Norman D, Delmonico F, Hanto D, Leichtman A, Danovitch G, Sayegh M, Shapiro R, Harmon W, Salvatierra O, Brennan D, McDiarmid S, Stock P, Pomfret L, Bennett W, Conti D, Metzger B, Sarwal M, Cosimi AB| | PubMed
  156. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease.
    Szot GL, Lee MR, Tavakol MM, Lang J, Dekovic F, Kerlan RK, Stock PG, Posselt AM| | PubMed
  157. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
    Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, Umetsu DT, Dekruyff RH| | PubMed
  158. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG, Fung J| | PubMed
  159. Balancing multiple and conflicting allocation goals: a logical path forward.
    Stock PG| | PubMed
  160. Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease.
    McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB| | PubMed
  161. Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.
    Gasser O, Bihl F, Sanghavi S, Rinaldo C, Rowe D, Hess C, Stablein D, Roland M, Stock P, Brander C| | PubMed
  162. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit.
    Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU| | PubMed
  163. Financial issues constraining the use of pancreata recovered for islet transplantation: a white paper.
    Markmann JF, Kaufman DB, Ricordi C, Schwab PM, Stock PG| | PubMed
  164. Tract-based spatial statistics of diffusion tensor imaging in adults with dyslexia.
    Richards T, Stevenson J, Crouch J, Johnson LC, Maravilla K, Stock P, Abbott R, Berninger V| | PubMed
  165. Hepatic progenitor cells from adult human livers for cell transplantation.
    Weiss TS, Lichtenauer M, Kirchner S, Stock P, Aurich H, Christ B, Brockhoff G, Kunz-Schughart LA, Jauch KW, Schlitt HJ, Thasler WE| | PubMed
  166. Hepatocytes derived from adult stem cells.
    Stock P, Staege MS, Müller LP, Sgodda M, Völker A, Volkmer I, Lützkendorf J, Christ B| | PubMed
  167. Human albumin preserves islet mass and function better than whole serum during pretransplantation islet culture.
    Lee RH, Carter J, Szot GL, Posselt A, Stock P| | PubMed
  168. Are HIV-infected patients candidates for liver transplantation?
    Samuel D, Weber R, Stock P, Duclos-Vallée JC, Terrault N| | PubMed
  169. Liver transplantation at UCSF--a 20-year experience.
    Hirose R, Yao F, Stock P, Roberts J, Ascher N| | PubMed
  170. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
    Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG| | PubMed
  171. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.
    Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, Carlson L, Benet LZ| | PubMed
  172. Evolving clinical strategies for transplantation in the HIV-positive recipient.
    Stock PG, Roland ME| | PubMed
  173. T-cell co-stimulatory molecules: their role in allergic immune reactions.
    Kallinich T, Beier KC, Wahn U, Stock P, Hamelmann E| | PubMed
  174. The rationale for the new deceased donor pancreas allocation schema.
    Stegall MD, Dean PG, Sung R, Guidinger MK, McBride MA, Sommers C, Basadonna G, Stock PG, Leichtman AB| | PubMed
  175. Solid organ transplantation: referral, management, and outcomes in HIV-infected patients.
    Roland ME, Carlson LL, Frassetto LA, Stock PG| | PubMed
  176. Solid organ transplantation is a reality for patients with HIV infection.
    Roland ME, Stock PG| | PubMed
  177. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications.
    Halpern SD, Asch DA, Shaked A, Stock P, Blumberg EA| | PubMed
  178. Liver transplantation in HIV-infected recipients.
    Roland ME, Stock PG| | PubMed
  179. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.
    Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG| | PubMed
  180. Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients.
    Carter JT, Melcher ML, Carlson LL, Roland ME, Stock PG| | PubMed
  181. Liver transplantation in HIV-seropositive individuals.
    Ragni MV, Belle SH, Im K, Fung J, Neff G, Roland M, Stock P, Heaton N, Humar A| | PubMed
  182. Antibody-mediated rejection of a pancreas allograft.
    Melcher ML, Olson JL, Baxter-Lowe LA, Stock PG, Posselt AM| | PubMed
  183. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
    Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE| | PubMed
  184. Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD.
    Stock PG| | PubMed
  185. Pretransplant islet culture: a comparison of four serum-free media using a murine model of islet transplantation.
    Carter J, Karmiol S, Nagy M, McElreath R, Calloway C, Motley A, Neill A, Jang HJ, Posselt A, Stock P| | PubMed
  186. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Frassetto L, Baluom M, Jacobsen W, Christians U, Roland ME, Stock PG, Carlson L, Benet LZ| | PubMed
  187. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV.
    Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E| | PubMed
  188. [Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients].
    Roland ME, Stock PG| | PubMed
  189. Current status of kidney and pancreas transplantation in the United States, 1994-2003.
    Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS| | PubMed
  190. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Posselt AM, Freise CE| | PubMed
  191. Ethical issues in split versus whole liver transplantation.
    Vulchev A, Roberts JP, Stock PG| | PubMed
  192. Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
    Quarcoo D, Weixler S, Joachim RA, Stock P, Kallinich T, Ahrens B, Hamelmann E| | PubMed
  193. Intraoperative fluid management of living donor versus cadaveric liver transplant recipients.
    Niemann CU, Hirose R, Stock P, Roberts JP, Mandell S, Spencer Yost C| | PubMed
  194. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P| | PubMed
  195. Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Freise CE| | PubMed
  196. Beta-cell replacement for type I diabetes.
    Stock PG, Bluestone JA| | PubMed
  197. Review of transplantation in HIV patients during the HAART era.
    Pelletier SJ, Norman SP, Christensen LL, Stock PG, Port FK, Merion RM| | PubMed
  198. Survival of human immunodeficiency virus-infected liver transplant recipients.
    Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, Heaton N, Humar A, Fung JF| | PubMed
  199. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Hirose R, Stock P| | PubMed
  200. Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation.
    Topp KS, Painter PL, Walcott S, Krasnoff JB, Adey D, Sakkas GK, Taylor J, McCormick K, TeNyenhuis M, Iofina M, Tomlanovich S, Stock P| | PubMed
  201. Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients.
    Roland ME, Lo B, Braff J, Stock PG| | PubMed
  202. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL| | PubMed
  203. Exercise capacity and muscle structure in kidney recipient and twin donor.
    Painter P, Taylor J, Wolcott S, Krasnoff J, Adey D, Tomlanovich S, Stock P, Topp K| | PubMed
  204. Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients.
    Painter PL, Topp KS, Krasnoff JB, Adey D, Strasner A, Tomlanovich S, Stock P| | PubMed
  205. Management of lymphoceles after renal transplantation: laparoscopic versus open drainage.
    Fuller TF, Kang SM, Hirose R, Feng S, Stock PG, Freise CE| | PubMed
  206. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
    Vincenti F, Stock P| | PubMed
  207. Organ donation from children with meningitis.
    Mirza D, Hastings M, Reyes J, Green M, Healey PJ, Stock P| | PubMed
  208. The year in review--ATC 2002.
    Stock PG| | PubMed
  209. Review of solid-organ transplantation in HIV-infected patients.
    Roland ME, Stock PG| | PubMed
  210. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
    Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG| | PubMed
  211. Solid organ transplantation in HIV-infected individuals.
    Roland M, Carlson L, Stock P| | PubMed
  212. Successful long-term outcomes using pediatric en bloc kidneys for transplantation.
    Hiramoto JS, Freise CE, Randall HR, Bretan PN, Tomlanovich S, Stock PG, Hirose R| | PubMed
  213. Solid organ transplantation in HIV-positive patients.
    Stock P, Roland M, Carlson L, Freise C, Hirose R, Terrault N, Frassetto L, Coates T, Roberts J, Ascher N| | PubMed
  214. Transplantation in the HIV+ patient.
    Kuo PC, Stock PG| | PubMed
  215. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
    Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R| | PubMed
  216. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
    Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R| | PubMed
  217. The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts.
    Lee CM, Carter JT, Randall HB, Hiose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey EJ| | PubMed
  218. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.
    Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG| | PubMed
  219. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
    O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG| | PubMed
  220. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
    O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG| | PubMed
  221. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
    Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG| | PubMed
  222. Liver transplantation for autoimmune hepatitis: rejection and recurrence.
    Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL| | PubMed
  223. Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes.
    Freise CE, Narumi S, Stock PG, Melzer JS| | PubMed
  224. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation.
    Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL| | PubMed
  225. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
    Gruessner RW, Bartlett ST, Burke GW, Stock PG| | PubMed
  226. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine.
    Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP| | PubMed
  227. Cardiorespiratory fitness in pancreas-kidney transplant recipients.
    Painter P, Tomlanovich S, Hector L, Ray K, Stock P, Melzer J| | PubMed
  228. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection.
    Kang SM, Lin Z, Ascher NL, Stock PG| | PubMed
  229. Increased morbidity and mortality of simultaneous pancreas-renal transplantation in patients over 49 years of age.
    Freise CE, Stock PG, Melzer JS| | PubMed
  230. Simultaneous islet-liver transplantation: preliminary results from the UC Islet Transplantation Consortium.
    Smith CV, Imagawa DK, Stock PG, Arita S, Une S, Kawahara T, Sakamoto Y, Ochiai M, Nagai T, Shevlin L, Mullen Y| | PubMed
  231. Immune response and myoblasts that express Fas ligand.
    Kang SM, Hoffmann A, Le D, Springer ML, Stock PG, Blau HM| | PubMed
  232. Evidence for primary genetic determination of heart rate regulation: chromosomal mapping of a genetic locus in the rat.
    Kreutz R, Struk B, Stock P, Hübner N, Ganten D, Lindpaintner K| | PubMed
  233. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction.
    Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S| | PubMed
  234. In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys.
    Mychaliska GB, Rice HE, Tarantal AF, Stock PG, Capper J, Garovoy MR, Olson JL, Cowan MJ, Harrison MR| | PubMed
  235. Re-evaluation of donor factors affecting islet isolation from human pancreas using a two-step digestion method.
    Une S, Atiya A, Ohtsuka S, Arita S, Kawahara T, Shevlin L, Stock P, Kenmochi T, Benhamou PY, Moldovan S, Brunicardi FC, Passaro E, Mullen Y| | PubMed
  236. Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras.
    Orloff SL, Hirose R, Lin Z, Narumi S, Stock PG, Ascher NL| | PubMed
  237. The Y chromosome. Epistatic and ecogenetic interactions in genetic hypertension.
    Kreutz R, Stock P, Struk B, Lindpaintner K| | PubMed
  238. Decreased mortality from technical failure improves results in pediatric liver transplantation.
    Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC| | PubMed
  239. Living related donor liver transplantation: the UCSF experience.
    Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL| | PubMed
  240. Strategies for tolerance induction: potential applications in living donor liver transplantation.
    Emond JC, Stock P, Roberts JP, Ascher NL| | PubMed
  241. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.
    Stock PG, Lantz M, Light S, Vincenti F| | PubMed
  242. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A| | PubMed
  243. Clinical islet transplantation experience of the University of California Islet Transplant Consortium.
    Brunicardi FC, Atiya A, Stock P, Kenmochi T, Une S, Benhamou PY, Watt PC, Miyamato M, Wantanabe Y, Nomura Y| | PubMed
  244. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation.
    Freise CE, Stock PG, Roberts JP, Melzer JS| | PubMed
  245. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
    Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F| | PubMed
  246. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, Stock PG| | UCSF Research Profile
  247. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW, Ascher NL, Melzer JS, Stock PG| | PubMed
  248. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
    Osorio RW, Ascher NL, Melzer JS, Stock PG| | PubMed
  249. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen.
    Osorio RW, Ascher NL, Stock PG| | PubMed
  250. Major histocompatibility complex class I deficiency prolongs islet allograft survival.
    Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG| | PubMed
  251. Nonoperative management of biliary leaks after orthotopic liver transplantation.
    Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP| | PubMed
  252. Isolation of functional MHC class I-deficient islet cells.
    Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG| | PubMed
  253. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity.
    Stock PG, Ascher NL, Osorio RW, Tomlanovich S, Lake JR, Nikolai B, Freise C, Roberts JP| | PubMed
  254. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets.
    Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE| | PubMed
  255. The alloimmune response against pancreatic islets is generated by both direct and indirect pathways.
    Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE| | PubMed
  256. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function.
    Kaufman DB, Morel P, Condie R, Field MJ, Rooney M, Tzardis P, Stock P, Sutherland DE| | PubMed
  257. Liver transplantation.
    Stock PG, Payne WD| | PubMed
  258. The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes.
    Stock PG, Ascher NL, Chen S, Bumgardner G, Field MJ, Sutherland DE| | PubMed
  259. Immunogenic potential of passenger leucocyte depleted murine islets in-vitro and in-vivo.
    Stock PG, Gores PF, Kaufmann DB, Platt JL, Sutherland DE| | PubMed
  260. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
    Stock PG, Ascher NL, Chen S, Bumgardner GL, Field MJ, Sutherland DE| | PubMed
  261. Comparative in vitro immunogenicity of cultured murine islets and hepatocytes.
    Meloche M, Bumgardner G, Stock P, Chen S, Ascher NL, Sutherland DE| | PubMed
  262. Factors influencing early survival after liver transplantation.
    Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL| | PubMed
  263. Frequency of precursor cytotoxic T lymphocytes correlates with outcome following heart-lung and pancreatic islet transplantation.
    Stock PG, Clemmings SM, Han D, Sutherland DE, Ascher NL| | PubMed
  264. Pediatric liver transplantation across ABO blood group barriers.
    Fischel RJ, Ascher NL, Payne WD, Freese DK, Stock P, Fasola C, Najarian JS| | PubMed
  265. Rapid infusion technique as a safe alternative to veno-venous bypass in orthotopic liver transplant (TX).
    Stock PG, Payne WD, Ascher NL, Roberts JP, Belani K, Estrin J, Najarian JS| | PubMed
  266. Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture.
    Stock PG, Ascher NL, Platt JL, Kaufman DB, Chen S, Field MJ, Sutherland DE| | PubMed
  267. Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells.
    Stock PG, Meloche M, Ascher NL, Chen S, Bach FH, Sutherland DE| | PubMed
  268. Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine.
    Chan GL, Erdmann GR, Gruber SA, Stock P, Chen S, Ascher NL, Canafax DM| | PubMed
  269. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
    Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS| | PubMed
  270. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis.
    Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA, Makowka L, Malatak J, Freese DK, Stock PG| | PubMed
  271. [Comparison of the results of liver transplantation in children and adults].
    Bumgardner GL, Stock PG, Payne WD, Najarian JS, Ascher NL| | PubMed
  272. In vitro generated allospecific cytolytic T lymphocytes injure pancreatic islets.
    Stock PG, Ascher NL, Kaufman DB, Chen S, Meloche M, Field MJ, Sutherland DE| | PubMed
  273. Cyclosporine suppresses immune-mediated pancreatic islet allograft primary nonfunction and enhances long-term functional survival.
    Kaufman DB, Rabe FL, Stock PG, van der Vliet JA, Platt J, Sutherland DE| | PubMed
  274. On the variability of outcome after islet allotransplantation.
    Kaufman DB, Rabe F, Platt JL, Stock PG, Sutherland DE| | PubMed
  275. Pancreatic islets generate allospecific cytolytic T lymphocytes in a mixed lymphocyte-islet culture.
    Stock P, Ascher N, Chen S, Field J, Platt J, Kaufman D, Sutherland D| | PubMed
  276. ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation.
    Stock PG, Sutherland DE, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS| | PubMed
  277. Functional and phenotypical characterization of activated T cells from intra-articular sites in inflammatory joint diseases. Possible modulation of the CD3 antigen.
    Jahn B, Burmester GR, Stock P, Rohwer P, Kalden JR| | PubMed
  278. Mixed islet-lymphocyte culture as a model for pancreatic islet immunogenicity and cell-mediated immune injury.
    Stock P, Ascher N, Kaufman D, Sutherland D| | PubMed
  279. Pediatric liver transplantation using combination immunosuppressive therapy.
    Stock PG, Ascher NL, Najarian JS| | PubMed
  280. Hepatitis-associated aplastic anemia after liver transplantation.
    Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL| | PubMed
  281. Renal subcapsular versus portal vein site for islet transplantation in mice.
    Stock PG, Gores P, Sutherland DE| | PubMed
  282. Detrimental effect of ABO mismatching in renal transplantation.
    Stock P, Sutherland DE, Fryd DS, Ascher NL, Payne WD, Simmons RL, Najarian JS| | PubMed
  283. Permanent acceptance of islet allografts in mice is not associated with immunologic tolerance.
    Gores PF, Platt JL, Rabe F, Stock P, Sutherland DE| | PubMed
  284. Plasma amino acid clearance predicts hepatic recovery after normothermic anoxia and cold preservation.
    Becker WK, Stock P, Fath JJ, Konstantinides FN, Ascher NL, Cerra FB| | PubMed
  285. Prognostic perioperative factors predicting the outcome of liver transplantation.
    Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL| | PubMed
  286. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
    St Cyr JA, Elick B, Freese D, Sharp H, Payne W, Bloomer J, Stock P, Snover D, Najarian JS, Ascher NL| | PubMed
  287. Intraarticular T lymphocytes in monoarticular and oligoarticular inflammatory joint diseases. Normal subset distribution and less numbers of activated T cells indicate major differences as compared to rheumatoid arthritis.
    Jahn B, Burmester GR, Gramatzki M, Weseloh G, Stock P, Kalden JR| | PubMed